New cannabis pill tested for severe cancer pain relief
NCT ID NCT06533657
Summary
This study is testing whether an oral medication called Trichomylin®, which contains three cannabis compounds, can help reduce pain in people with advanced cancer. It will involve about 20 adults who are already taking stable opioid pain medication but still experience moderate to severe pain. The main goals are to see if the medication is safe and if it can lower participants' daily pain scores.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CancerCare Manitoba
Winnipeg, Manitoba, Canada
-
Centre hospitalier de l'Université de Montréal
Montreal, Quebec, H2X 0C1, Canada
-
The Research Institute of the McGill University Health Centre
Montreal, Quebec, H3H 2R9, Canada
Conditions
Explore the condition pages connected to this study.